Trial Scorecard: REDEFINE 1 and 2 US$ 29.35 Min. order: 1 piece ★★★★★ 4.8 (205 reviews) Sold : Login>>
Novo Nosedives on Underwhelming CagriSema Phase III Weight-Loss Data US$ 25.70 Min. order: 1 piece ★★★★★ 4.6 (233 reviews) Sold : Login>>
Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 21.01 Min. order: 1 piece ★★★★★ 5.0 (275 reviews) Sold : Login>>
Novo Nordisk shares higher on positive Phase 3 trial results for obesity drug Cagrilintide US$ 29.44 Min. order: 1 piece ★★★★★ 4.2 (224 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 23.18 Min. order: 1 piece ★★★★★ 4.8 (295 reviews) Sold : Login>>
Novo Nordisk's Cagrilintide shows promising weight loss in REDEFINE-1 sub-analysis, unveiled at EASD 2025 US$ 21.85 Min. order: 1 piece ★★★★★ 4.8 (122 reviews) Sold : Login>>